Geulah Livshits
Stock Analyst at Chardan Capital
(4.34)
# 1,337
Out of 4,690 analysts
644
Total ratings
38.1%
Success rate
9.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGX Metagenomi Therapeutics | Maintained: Buy | $7 → $5 | $1.19 | +320.17% | 8 | Jul 7, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $240 | $149.97 | +60.03% | 12 | May 20, 2026 | |
| IMTX Immatics | Reiterated: Buy | $25 | $9.45 | +164.55% | 22 | May 19, 2026 | |
| IMRX Immuneering | Reiterated: Buy | $20 | $4.99 | +300.80% | 15 | May 19, 2026 | |
| SNTI Senti Biosciences Holdings | Reiterated: Buy | $13 → $12 | $0.377 | +3,083.02% | 12 | May 15, 2026 | |
| TNYA Tenaya Therapeutics | Reiterated: Buy | $8 | $0.6901 | +1,059.25% | 21 | May 15, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $15 | $9.77 | +53.53% | 12 | May 13, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $17 | $4.86 | +249.79% | 13 | May 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $11 | $3.86 | +184.97% | 39 | May 10, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $26 | $14.67 | +77.23% | 17 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.61 | +149.31% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $14 | $8.01 | +74.78% | 53 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.77 | +107.97% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 → $4 | $3.16 | +26.58% | 43 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $14.57 | +51.00% | 1 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $57.72 | +31.67% | 57 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 | $351.46 | -8.10% | 24 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $30 | $12.87 | +133.10% | 51 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $21 | $4.52 | +364.60% | 17 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $137.99 | - | 41 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €1.00 | €0.27 | +267.65% | 8 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $7 | $2.03 | n/a | 7 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.07 | n/a | 23 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 → $36 | $13.82 | n/a | 18 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $48.72 | n/a | 6 | Aug 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.12 | n/a | 11 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2109 | n/a | 12 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.59 | n/a | 3 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $8.89 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €15.00 | €0.13 | n/a | 7 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $76 | $9.66 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $6 | $3.54 | n/a | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $15 | $15.03 | n/a | 10 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $20 | $41.20 | n/a | 3 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.0131 | n/a | 5 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $21 | $27.57 | n/a | 2 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 17 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $48 | $15.50 | n/a | 9 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $0.8857 | n/a | 1 | Jun 4, 2020 |
Metagenomi Therapeutics
Jul 7, 2026
Maintained: Buy
Price Target: $7 → $5
Current: $1.19
Upside: +320.17%
Palvella Therapeutics
May 20, 2026
Reiterated: Buy
Price Target: $240
Current: $149.97
Upside: +60.03%
Immatics
May 19, 2026
Reiterated: Buy
Price Target: $25
Current: $9.45
Upside: +164.55%
Immuneering
May 19, 2026
Reiterated: Buy
Price Target: $20
Current: $4.99
Upside: +300.80%
Senti Biosciences Holdings
May 15, 2026
Reiterated: Buy
Price Target: $13 → $12
Current: $0.377
Upside: +3,083.02%
Tenaya Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $0.6901
Upside: +1,059.25%
Solid Biosciences
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $9.77
Upside: +53.53%
Lexeo Therapeutics
May 11, 2026
Reiterated: Buy
Price Target: $17
Current: $4.86
Upside: +249.79%
Rocket Pharmaceuticals
May 10, 2026
Reiterated: Buy
Price Target: $11
Current: $3.86
Upside: +184.97%
4D Molecular Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $26
Current: $14.67
Upside: +77.23%
May 8, 2026
Reiterated: Buy
Price Target: $9
Current: $3.61
Upside: +149.31%
May 7, 2026
Reiterated: Buy
Price Target: $16 → $14
Current: $8.01
Upside: +74.78%
May 6, 2026
Reiterated: Buy
Price Target: $12
Current: $5.77
Upside: +107.97%
May 5, 2026
Reiterated: Buy
Price Target: $3.5 → $4
Current: $3.16
Upside: +26.58%
May 5, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $14.57
Upside: +51.00%
May 4, 2026
Reiterated: Buy
Price Target: $76
Current: $57.72
Upside: +31.67%
May 4, 2026
Reiterated: Buy
Price Target: $323
Current: $351.46
Upside: -8.10%
Apr 27, 2026
Maintained: Buy
Price Target: $27 → $30
Current: $12.87
Upside: +133.10%
Nov 12, 2025
Maintained: Buy
Price Target: $120 → $21
Current: $4.52
Upside: +364.60%
Oct 7, 2025
Rated: Hold
Price Target: n/a
Current: $137.99
Upside: -
Sep 17, 2025
Maintained: Buy
Price Target: €1.00
Current: €0.27
Upside: +267.65%
Mar 24, 2025
Maintained: Buy
Price Target: $11 → $7
Current: $2.03
Upside: n/a
Jan 29, 2024
Reiterated: Buy
Price Target: n/a
Current: $5.07
Upside: n/a
Dec 21, 2023
Reiterated: Buy
Price Target: $41 → $36
Current: $13.82
Upside: n/a
Aug 25, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $48.72
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $12
Current: $3.12
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.2109
Upside: n/a
Jan 6, 2023
Rated: Hold
Price Target: n/a
Current: $6.59
Upside: n/a
Dec 14, 2022
Maintained: Buy
Price Target: $11
Current: $8.89
Upside: n/a
Jul 28, 2022
Reiterated: Buy
Price Target: €15.00
Current: €0.13
Upside: n/a
Mar 29, 2022
Maintained: Buy
Price Target: $90 → $76
Current: $9.66
Upside: n/a
Mar 9, 2022
Reiterated: Hold
Price Target: $4 → $6
Current: $3.54
Upside: n/a
Feb 22, 2022
Reiterated: Buy
Price Target: $25 → $15
Current: $15.03
Upside: n/a
Jan 5, 2022
Reiterated: Buy
Price Target: $22 → $20
Current: $41.20
Upside: n/a
Dec 17, 2021
Reiterated: Buy
Price Target: $30
Current: $0.0131
Upside: n/a
Aug 20, 2021
Reiterated: Buy
Price Target: $18 → $21
Current: $27.57
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Oct 14, 2020
Maintained: Buy
Price Target: $30 → $48
Current: $15.50
Upside: n/a
Jun 4, 2020
Initiated Coverage: Buy
Price Target: $28
Current: $0.8857
Upside: n/a